35H Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Homology Medicines Inc

Watchlist Manager

Watchlist

Price: 14.85 EUR Market Closed

Market Cap: €4.1B

H	Homology Medicines Inc SWB:35H	US
	Fabrinet NYSE:FN	KY
	Jacquet Metals SA PAR:JCQ	FR
C	Charles River Laboratories International Inc F:RV6	US
	Swatch Group AG OTC:SWGAF	CH
	Diamondrock Hospitality Co NYSE:DRH	US
S	Sompo Holdings Inc XBER:ANK	JP
	Elevance Health Inc NYSE:ELV	US

Profitability Summary

Homology Medicines Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Exceptional Operating Margin

31%

Negative 3Y Average Operating Margin

-8 283%

Operating Margin is Increasing

-4 570% > 31%

Exceptional Net Margin

55%

Negative 3Y Average Net Margin

-8 995%

Net Margin is Increasing

-4 797% > 55%

Negative Free Cash Flow Margin

-62%

Negative 3Y Average Free Cash Flow Margin

-8 338%

Free Cash Flow Margin is Increasing

-3 712% > -62%

Exceptional ROE

125%

Exceptional 3Y Average ROE

Negative 3Y Average ROIC

-392%

ROIC is Increasing

-267% > 141%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.